Neuroblastoma News and Research

Latest Neuroblastoma News and Research

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients.

9 Feb 2020

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects.

31 Jan 2020

Novel computer algorithm identifies promising new treatment for neuroblastoma

Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma.

7 Jan 2020

Extrachromosomal circular DNA can contribute to cancer development in children

Cancer development is associated with the gradual accumulation of DNA defects over time. Thus, cancer is considered an age-related disease.

17 Dec 2019

Study sheds light on the factors at play in neuroblastoma metastasis

Neuroblastoma can grow and spread in the body very aggressively, making it very difficult to treat. New research has shed important light on the factors at play in the metastasis of neuroblastoma, which could potentially lead to new treatment strategies.

11 Dec 2019

Study identifies improved treatment option for neuroblastoma

Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, through genome sequencing, that the protein ALK and the cancer gene PIM1 are involved in the development of this tumor.

4 Dec 2019

CD44 protein helps identify mother cells responsible for aggressive nature of neuroblastoma

A group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla - IBiS) has published a study in which they determine that a protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old.

27 Nov 2019

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cell is by copying itself over and over, like a Xerox machine.

21 Nov 2019

Researchers uncover new and unexploited drug target for childhood cancer

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma, by uncovering a new and as-yet unexploited target in cancer cells that therapeutic drugs can be aimed at.

12 Nov 2019

Preclinical data on new drug combination to treat neuroblastoma published

Neuroblastoma is the most common cancer outside of the brain in infants and young children and often fails to respond to therapy. Though it can appear in several areas of the body, it commonly develops as a solid tumor most frequently found in or adjacent to the adrenal glands, which sit atop the kidneys.

10 Nov 2019

St. Jude Children's Research Hospital and IAEA team up to combat childhood cancers

The International Atomic Energy Agency and St. Jude Children's Research Hospital are joining forces to combat childhood cancers in developing countries, where children are four times more likely to die of the disease than in high-income countries due to a lack of affordable treatment and quality care options.

18 Oct 2019

Researchers identify targeted therapy for adolescent patients with neuroblastoma

Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options, according to a study published in October in Cancer Cell.

17 Oct 2019

New algorithm can help reduce therapy for some patients with intermediate-risk neuroblastoma

A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.

2 Oct 2019

Ruthenium probes shed new light on cause of Alzheimer's disease

Rice University researchers have found a way to track the formation of soluble amyloid beta peptide aggregates implicated in the onset of Alzheimer's disease.

23 Sep 2019

Removing tumor's protective wall could help boost the effects of cancer treatments

Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).

26 Aug 2019

Study aims to reduce therapy for subsets of patients with intermediate-risk neuroblastoma

Each year, approximately 750 patients are diagnosed with neuroblastoma in North America, the most common form of cancer in infants less than one year old.

8 Aug 2019

Australian researchers discover gene that plays key role in aggressive childhood cancer

Neuroblastoma accounts for 15% of total childhood cancer deaths. The survival rate of high-risk neuroblastoma patients is 50%.

27 Jul 2019

Children with birth defects have elevated cancer risk, study reveals

Childhood cancer is a rare occurrence in the overall population but may be somewhat more frequent in children born with birth defects.

26 Jun 2019

Study aims at developing new therapies to fight childhood cancer

Researchers from the Department of Cellular Biology at the University of Seville and the Seville Institute of Biomedicine, Pablo Vicente and Doctor Luisma Escudero, in close collaboration with the researcher Rebecca Burgos and other members of the group of Doctor Rosa Noguera have published a study aimed at developing new therapies to fight childhood cancer.

12 Jun 2019

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.

31 May 2019

Neuroblastoma News and Research

Latest Neuroblastoma News and Research

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

Novel computer algorithm identifies promising new treatment for neuroblastoma

Extrachromosomal circular DNA can contribute to cancer development in children

Study sheds light on the factors at play in neuroblastoma metastasis

Study identifies improved treatment option for neuroblastoma

CD44 protein helps identify mother cells responsible for aggressive nature of neuroblastoma

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

Researchers uncover new and unexploited drug target for childhood cancer

Preclinical data on new drug combination to treat neuroblastoma published

St. Jude Children's Research Hospital and IAEA team up to combat childhood cancers

Researchers identify targeted therapy for adolescent patients with neuroblastoma

New algorithm can help reduce therapy for some patients with intermediate-risk neuroblastoma

Ruthenium probes shed new light on cause of Alzheimer's disease

Removing tumor's protective wall could help boost the effects of cancer treatments

Study aims to reduce therapy for subsets of patients with intermediate-risk neuroblastoma

Australian researchers discover gene that plays key role in aggressive childhood cancer

Children with birth defects have elevated cancer risk, study reveals

Study aims at developing new therapies to fight childhood cancer

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Neuroblastoma News and Research

Latest Neuroblastoma News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in